Overweight or Obese. Obesity due to excess calories
Conditions
Interventions
Treatment - Drugs
Control group: 25 mcg Lactose for 90 days
Intervention group: 1000 IU Vitamin D for 90 days
Intervention 1: Control group: 25 mcg Lactose for 90 days. Intervention 2: Intervention group: 1000 IU Vitamin D for 90 days.
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age of 18–45 years (before menopause), Body Mass Index=25 (BMI; in kg/m2 calculated as weight in kilograms divided by the square of the height in meters), No Use of Dietary Supplements, Absence of Menopause, Stable Body Weight (body weight change =3 kg) for 2 mo before intervention, Good general Health, No Smoking, Normal Blood Pressure Values (=160/95mm Hg), Cholesterol Concentrations not Requiring Pharmaceutical Treatment, Normal Thyroid Function, No use of Medication that could affect body weight, No participation in another clinical trial within 6 mo of screening, No breastfeeding or pregnancy. Exclusion criteria: History of Osteoporosis, Rheumatic Disease, Diabetes Mellitus, Epilepsy, Renal Disease under Hemodialysis, Liver disease, Gastrointestinal Disease, Myocardial infarction, Angina Pectoris, Heart Valve Disease, or Pacemaker Implantation. Compliance less than 70 out of 90 prescribed tablets
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overweight or Obese. Timepoint: Every Month for 3 months. Method of measurement: Anthropometric Index, Bioelectric Impedance. | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin Resistance. Timepoint: 3 months. Method of measurement: 75-OGTT.;Hyperlipidemia. Timepoint: 3 months. Method of measurement: serum lipid levels.;Hypertension. Timepoint: Every Month for 3 months. Method of measurement: Measurement of Blood Pressure. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed